Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.730646
Abstract: Purpose We investigated potential factors, including clinicopathological features, treatment modalities, neutrophil-to-lymphocyte ratio (NLR), carbohydrate antigen (CA) 19-9 level, tumor responses correlating with overall survival (OS), local progression (LP), and distant metastases (DMs), in patients with… read more here.
Keywords: prognostic factors; competing risk; adjusted shr; outcomes unresectable ... See more keywords
Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon.
Sign Up to like & getrecommendations! Published in 2017 at "Indian journal of cancer"
DOI: 10.4103/ijc.ijc_377_17
Abstract: BACKGROUND Outcomes and survival of truly unresectable locally advanced pancreatic cancers (LAPC) is often reported along with borderline resectable pancreatic cancers especially from a real world cohort. METHODS The audit of LAPC patients, diagnosed based… read more here.
Keywords: real world; advanced pancreatic; locally advanced; outcomes unresectable ... See more keywords